311 related articles for article (PubMed ID: 28723904)
1. Impact of mass drug administration for elimination of lymphatic filariasis in Nepal.
Ojha CR; Joshi B; Kc KP; Dumre SP; Yogi KK; Bhatta B; Adhikari T; Crowley K; Marasini BR
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005788. PubMed ID: 28723904
[TBL] [Abstract][Full Text] [Related]
2. Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
Garchitorena A; Raza-Fanomezanjanahary EM; Mioramalala SA; Chesnais CB; Ratsimbasoa CA; Ramarosata H; Bonds MH; Rabenantoandro H
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006780. PubMed ID: 30222758
[TBL] [Abstract][Full Text] [Related]
3. Assessment of microfilaremia in 'hotspots' of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance.
Mehta PK; Maharjan M
PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011932. PubMed ID: 38295107
[TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis.
Burgert-Brucker CR; Zoerhoff KL; Headland M; Shoemaker EA; Stelmach R; Karim MJ; Batcho W; Bougouma C; Bougma R; Benjamin Didier B; Georges N; Marfo B; Lemoine JF; Pangaribuan HU; Wijayanti E; Coulibaly YI; Doumbia SS; Rimal P; Salissou AB; Bah Y; Mwingira U; Nshala A; Muheki E; Shott J; Yevstigneyeva V; Ndayishimye E; Baker M; Kraemer J; Brady M
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008301. PubMed ID: 32479495
[TBL] [Abstract][Full Text] [Related]
5. How Thailand eliminated lymphatic filariasis as a public health problem.
Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
[TBL] [Abstract][Full Text] [Related]
6. Progress on elimination of lymphatic filariasis in Sierra Leone.
Koroma JB; Sesay S; Conteh A; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y
Parasit Vectors; 2018 Jun; 11(1):334. PubMed ID: 29866207
[TBL] [Abstract][Full Text] [Related]
7. Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.
Modi A; Gamit S; Jesalpura BS; Kurien G; Kosambiya JK
PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005476. PubMed ID: 28369129
[TBL] [Abstract][Full Text] [Related]
8. Achievements and challenges of lymphatic filariasis elimination in Sierra Leone.
Bah YM; Paye J; Bah MS; Conteh A; Redwood-Sawyerr V; Sonnie M; Veinoglou A; Koroma JB; Hodges MH; Zhang Y
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008877. PubMed ID: 33370270
[TBL] [Abstract][Full Text] [Related]
9. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Ranasinghe USB; Weil GJ
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007365. PubMed ID: 31009482
[TBL] [Abstract][Full Text] [Related]
10. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
[TBL] [Abstract][Full Text] [Related]
11. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic Filariasis Elimination Status:
Matapo BB; Mpabalwani EM; Kaonga P; Simuunza MC; Bakyaita N; Masaninga F; Siyumbwa N; Siziya S; Shamilimo F; Muzongwe C; Mwase ET; Sikasunge CS
Trop Med Infect Dis; 2023 Jun; 8(7):. PubMed ID: 37505629
[TBL] [Abstract][Full Text] [Related]
13. Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities.
Biritwum NK; Frempong KK; Verver S; Odoom S; Alomatu B; Asiedu O; Kontoroupis P; Yeboah A; Hervie ET; Marfo B; Boakye DA; de Vlas SJ; Gyapong JO; Stolk WA
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007115. PubMed ID: 31398203
[TBL] [Abstract][Full Text] [Related]
14. Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration.
Mayfield HJ; Sartorius B; Sheridan S; Howlett M; Martin BM; Thomsen R; Tofaeono-Pifeleti R; Viali S; Graves PM; Lau CL
PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012236. PubMed ID: 38935622
[TBL] [Abstract][Full Text] [Related]
15. The significant scale up and success of Transmission Assessment Surveys 'TAS' for endgame surveillance of lymphatic filariasis in Bangladesh: One step closer to the elimination goal of 2020.
Shamsuzzaman AK; Haq R; Karim MJ; Azad MB; Mahmood AS; Khair A; Rahman MM; Hafiz I; Ramaiah KD; Mackenzie CD; Mableson HE; Kelly-Hope LA
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005340. PubMed ID: 28141812
[TBL] [Abstract][Full Text] [Related]
16. Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration.
McLure A; Graves PM; Lau C; Shaw C; Glass K
Epidemics; 2022 Sep; 40():100591. PubMed ID: 35816826
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.
da Silva JSF; Braga C; Duarte FM; Oliveira P; Feitosa Luna C; Marcondes M; Araújo J; Grilis MR; de Souza Melo PFA; Brandão E; Rocha A
Pathog Glob Health; 2018 Jul; 112(5):274-280. PubMed ID: 30111259
[TBL] [Abstract][Full Text] [Related]
18. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
[TBL] [Abstract][Full Text] [Related]
19. Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Dassanayaka TDM; Punchihewa MW; Ranasinghe USB; Weil GJ
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006066. PubMed ID: 29084213
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
Swaminathan S; Perumal V; Adinarayanan S; Kaliannagounder K; Rengachari R; Purushothaman J
PLoS Negl Trop Dis; 2012; 6(11):e1926. PubMed ID: 23209865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]